Waldhauser K M, Brecht K, Hebeisen S, Ha H R, Konrad D, Bur D, Krähenbühl S
Division of Clinical Pharmacology & Toxicology, Department of Research, University Hospital Basel, Basel, Switzerland.
Br J Pharmacol. 2008 Oct;155(4):585-95. doi: 10.1038/bjp.2008.287. Epub 2008 Jul 7.
Amiodarone (2-n-butyl-3-[3,5 diiodo-4-diethylaminoethoxybenzoyl]-benzofuran, B2-O-CH(2)CH(2)-N-diethyl) is an effective class III antiarrhythmic drug demonstrating potentially life-threatening organ toxicity. The principal aim of the study was to find amiodarone analogues that retained human ether-a-go-go-related protein (hERG) channel inhibition but with reduced cytotoxicity.
We synthesized amiodarone analogues with or without a positively ionizable nitrogen in the phenolic side chain. The cytotoxic properties of the compounds were evaluated using HepG2 (a hepatocyte cell line) and A549 cells (a pneumocyte line). Interactions of all compounds with the hERG channel were measured using pharmacological and in silico methods.
Compared with amiodarone, which displayed only a weak cytotoxicity, the mono- and bis-desethylated metabolites, the further degraded alcohol (B2-O-CH(2)-CH(2)-OH), the corresponding acid (B2-O-CH(2)-COOH) and, finally, the newly synthesized B2-O-CH(2)-CH(2)-N-pyrrolidine were equally or more toxic. Conversely, structural analogues such as the B2-O-CH(2)-CH(2)-N-diisopropyl and the B2-O-CH(2)-CH(2)-N-piperidine were significantly less toxic than amiodarone. Cytotoxicity was associated with a drop in the mitochondrial membrane potential, suggesting mitochondrial involvement. Pharmacological and in silico investigations concerning the interactions of these compounds with the hERG channel revealed that compounds carrying a basic nitrogen in the side chain display a much higher affinity than those lacking such a group. Specifically, B2-O-CH(2)-CH(2)-N-piperidine and B2-O-CH(2)-CH(2)-N-pyrrolidine revealed a higher affinity towards hERG channels than amiodarone.
Amiodarone analogues with better hERG channel inhibition and cytotoxicity profiles than the parent compound have been identified, demonstrating that cytotoxicity and hERG channel interaction are mechanistically distinct and separable properties of the compounds.
胺碘酮(2 - 正丁基 - 3 - [3,5 - 二碘 - 4 - 二乙氨基乙氧基苯甲酰基] - 苯并呋喃,B2 - O - CH(2)CH(2) - N - 二乙)是一种有效的III类抗心律失常药物,但具有潜在危及生命的器官毒性。本研究的主要目的是寻找保留人类醚 - 去极化相关蛋白(hERG)通道抑制作用但细胞毒性降低的胺碘酮类似物。
我们合成了酚侧链中带有或不带有可离子化正氮的胺碘酮类似物。使用HepG2(一种肝细胞系)和A549细胞(一种肺细胞系)评估这些化合物的细胞毒性特性。使用药理学和计算机模拟方法测量所有化合物与hERG通道的相互作用。
与仅显示弱细胞毒性的胺碘酮相比,单去乙基和双去乙基代谢物、进一步降解的醇(B2 - O - CH(2) - CH(2) - OH)、相应的酸(B2 - O - CH(2) - COOH)以及最后新合成的B2 - O - CH(2) - CH(2) - N - 吡咯烷具有同等或更高的毒性。相反,结构类似物如B2 - O - CH(2) - CH(2) - N - 二异丙基和B2 - O - CH(2) - CH(2) - N - 哌啶的毒性明显低于胺碘酮。细胞毒性与线粒体膜电位下降有关,提示线粒体参与其中。关于这些化合物与hERG通道相互作用的药理学和计算机模拟研究表明,侧链带有碱性氮的化合物显示出比缺乏此类基团化合物更高的亲和力。具体而言,B2 - O - CH(2) - CH(2) - N - 哌啶和B2 - O - CH(2) - CH(2) - N - 吡咯烷对hERG通道的亲和力高于胺碘酮。
已鉴定出比母体化合物具有更好的hERG通道抑制和细胞毒性特征的胺碘酮类似物,表明细胞毒性和hERG通道相互作用是这些化合物在机制上不同且可分离的特性。